APO Research
Talk to an analyst

APO RESEARCH · REPORT

Continuous Glucose Monitor (CGM) Solution

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Continuous Glucose Monitor (CGM) Solution Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchContinuous Glucose Monitor (CGM) Solution Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Continuous Glucose Monitor (CGM) Solution Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Continuous Glucose Monitor (CGM) Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Continuous Glucose Monitor (CGM) Solution Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Continuous Glucose Monitor (CGM) Solution Market Analysis and Forecast 2026-2032258 pages · $4,950 USD

Market perspective

The global Continuous Glucose Monitor (CGM) Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Continuous Glucose Monitor (CGM) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Continuous Glucose Monitor (CGM) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Continuous Glucose Monitor (CGM) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Continuous Glucose Monitor (CGM) Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Continuous Glucose Monitor (CGM) Solution market include Roche, Nutrisense, Levels Health, Eversense, Abbott, Dexcom, Medtronic, Changsha Sinocare and Beijing Yicheng Bioelectronics Technology, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Continuous Glucose Monitor (CGM) Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Continuous Glucose Monitor (CGM) Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Continuous Glucose Monitor (CGM) Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Continuous Glucose Monitor (CGM) Solution market.

Continuous Glucose Monitor (CGM) Solution Segment by Company

Roche

Nutrisense

Levels Health

Eversense

Abbott

Dexcom

Medtronic

Changsha Sinocare

Beijing Yicheng Bioelectronics Technology

Ottai Technology (Wuxi)

Hangzhou MicroTech Medical

Continuous Glucose Monitor (CGM) Solution Segment by Type

Hardware

Software

Continuous Glucose Monitor (CGM) Solution Segment by Application

Clinical Treatment

Sports & Fitness

Others

Continuous Glucose Monitor (CGM) Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Continuous Glucose Monitor (CGM) Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Continuous Glucose Monitor (CGM) Solution key companies, revenue, market share, and recent developments.

3. To split the Continuous Glucose Monitor (CGM) Solution breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Continuous Glucose Monitor (CGM) Solution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Continuous Glucose Monitor (CGM) Solution significant trends, drivers, influence factors in global and regions.

6. To analyze Continuous Glucose Monitor (CGM) Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Continuous Glucose Monitor (CGM) Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Continuous Glucose Monitor (CGM) Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Continuous Glucose Monitor (CGM) Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Continuous Glucose Monitor (CGM) Solution industry.

Chapter 3: Detailed analysis of Continuous Glucose Monitor (CGM) Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Continuous Glucose Monitor (CGM) Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Continuous Glucose Monitor (CGM) Solution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Continuous Glucose Monitor (CGM) Solution Industry Trends Table 2. Continuous Glucose Monitor (CGM) Solution Industry Drivers Table 3. Continuous Glucose Monitor (CGM) Solution Industry Opportunities and Challenges Table 4. Continuous Glucose Monitor (CGM) Solution Industry Restraints Table 5. Global Continuous Glucose Monitor (CGM) Solution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Continuous Glucose Monitor (CGM) Solution Revenue Share by Company (2021-2026) Table 7. Global Continuous Glucose Monitor (CGM) Solution Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Continuous Glucose Monitor (CGM) Solution Key Company Manufacturing Base & Headquarters Table 9. Global Continuous Glucose Monitor (CGM) Solution Company, Product Type & Application Table 10. Global Continuous Glucose Monitor (CGM) Solution Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Continuous Glucose Monitor (CGM) Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hardware Table 15. Significant Companies of Software Table 16. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type (2021-2026) Table 20. Global Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Clinical Treatment Table 22. Significant Companies of Sports & Fitness Table 23. Significant Companies of Others Table 24. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application (2021-2026) Table 28. Global Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application (2027-2032) Table 29. Global Continuous Glucose Monitor (CGM) Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Continuous Glucose Monitor (CGM) Solution Sales Value Share by Region (2021-2026) Table 32. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Continuous Glucose Monitor (CGM) Solution Sales Value Share by Region (2027-2032) Table 34. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Continuous Glucose Monitor (CGM) Solution Sales Value Market Share by Country (2021-2026) Table 37. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Continuous Glucose Monitor (CGM) Solution Sales Value Market Share by Country (2027-2032) Table 39. Roche Company Information Table 40. Roche Business Overview Table 41. Roche Continuous Glucose Monitor (CGM) Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Roche Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 43. Roche Recent Development Table 44. Nutrisense Company Information Table 45. Nutrisense Business Overview Table 46. Nutrisense Continuous Glucose Monitor (CGM) Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Nutrisense Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 48. Nutrisense Recent Development Table 49. Levels Health Company Information Table 50. Levels Health Business Overview Table 51. Levels Health Continuous Glucose Monitor (CGM) Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Levels Health Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 53. Levels Health Recent Development Table 54. Eversense Company Information Table 55. Eversense Business Overview Table 56. Eversense Continuous Glucose Monitor (CGM) Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Eversense Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 58. Eversense Recent Development Table 59. Abbott Company Information Table 60. Abbott Business Overview Table 61. Abbott Continuous Glucose Monitor (CGM) Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Abbott Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 63. Abbott Recent Development Table 64. Dexcom Company Information Table 65. Dexcom Business Overview Table 66. Dexcom Continuous Glucose Monitor (CGM) Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Dexcom Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 68. Dexcom Recent Development Table 69. Medtronic Company Information Table 70. Medtronic Business Overview Table 71. Medtronic Continuous Glucose Monitor (CGM) Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Medtronic Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 73. Medtronic Recent Development Table 74. Changsha Sinocare Company Information Table 75. Changsha Sinocare Business Overview Table 76. Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 78. Changsha Sinocare Recent Development Table 79. Beijing Yicheng Bioelectronics Technology Company Information Table 80. Beijing Yicheng Bioelectronics Technology Business Overview Table 81. Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 83. Beijing Yicheng Bioelectronics Technology Recent Development Table 84. Ottai Technology (Wuxi) Company Information Table 85. Ottai Technology (Wuxi) Business Overview Table 86. Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 88. Ottai Technology (Wuxi) Recent Development Table 89. Hangzhou MicroTech Medical Company Information Table 90. Hangzhou MicroTech Medical Business Overview Table 91. Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Product Portfolio Table 93. Hangzhou MicroTech Medical Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Continuous Glucose Monitor (CGM) Solution Product Image Figure 2. Global Continuous Glucose Monitor (CGM) Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032) & (US$ Million) Figure 4. Global Continuous Glucose Monitor (CGM) Solution Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hardware Image Figure 8. Software Image Figure 9. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Continuous Glucose Monitor (CGM) Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type (2021-2032) Figure 12. Clinical Treatment Image Figure 13. Sports & Fitness Image Figure 14. Others Image Figure 15. Global Continuous Glucose Monitor (CGM) Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Continuous Glucose Monitor (CGM) Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application (2021-2032) Figure 18. Global Continuous Glucose Monitor (CGM) Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Continuous Glucose Monitor (CGM) Solution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Continuous Glucose Monitor (CGM) Solution Sales Value (2021-2032) & (US$ Million) Figure 21. North America Continuous Glucose Monitor (CGM) Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Continuous Glucose Monitor (CGM) Solution Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Continuous Glucose Monitor (CGM) Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Continuous Glucose Monitor (CGM) Solution Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Continuous Glucose Monitor (CGM) Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Continuous Glucose Monitor (CGM) Solution Sales Value (2021-2032) & (US$ Million) Figure 27. South America Continuous Glucose Monitor (CGM) Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Continuous Glucose Monitor (CGM) Solution Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Continuous Glucose Monitor (CGM) Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware
  • Software
Applications
  • Clinical Treatment
  • Sports & Fitness
  • Others
Companies covered
  • Roche
  • Nutrisense
  • Levels Health
  • Eversense
  • Abbott
  • Dexcom
  • Medtronic
  • Changsha Sinocare
  • Beijing Yicheng Bioelectronics Technology
  • Ottai Technology (Wuxi)
  • Hangzhou MicroTech Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Continuous Glucose Monitor (CGM) Solution Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Continuous Glucose Monitor (CGM) Solution Market Dynamics
  1. 2.1 Continuous Glucose Monitor (CGM) Solution Industry Trends
  2. 2.2 Continuous Glucose Monitor (CGM) Solution Industry Drivers
  3. 2.3 Continuous Glucose Monitor (CGM) Solution Industry Opportunities and Challenges
  4. 2.4 Continuous Glucose Monitor (CGM) Solution Industry Restraints
3 Continuous Glucose Monitor (CGM) Solution Market by Company
  1. 3.1 Global Continuous Glucose Monitor (CGM) Solution Company Revenue Ranking in 2025
  2. 3.2 Global Continuous Glucose Monitor (CGM) Solution Revenue by Company (2021-2026)
  3. 3.3 Global Continuous Glucose Monitor (CGM) Solution Company Ranking (2024-2026)
  4. 3.4 Global Continuous Glucose Monitor (CGM) Solution Company Manufacturing Base and Headquarters
  5. 3.5 Global Continuous Glucose Monitor (CGM) Solution Company Product Type and Application
  6. 3.6 Global Continuous Glucose Monitor (CGM) Solution Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Continuous Glucose Monitor (CGM) Solution Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Continuous Glucose Monitor (CGM) Solution Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Continuous Glucose Monitor (CGM) Solution Market by Type
  1. 4.1 Continuous Glucose Monitor (CGM) Solution Type Introduction
  2. 4.1.1 Hardware
  3. 4.1.2 Software
  4. 4.2 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Type
  5. 4.2.1 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Type (2021-2032)
  7. 4.2.3 Global Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type (2021-2032)
5 Continuous Glucose Monitor (CGM) Solution Market by Application
  1. 5.1 Continuous Glucose Monitor (CGM) Solution Application Introduction
  2. 5.1.1 Clinical Treatment
  3. 5.1.2 Sports & Fitness
  4. 5.1.3 Others
  5. 5.2 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Application
  6. 5.2.1 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Application (2021-2032)
  8. 5.2.3 Global Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application (2021-2032)
6 Continuous Glucose Monitor (CGM) Solution Regional Value Analysis
  1. 6.1 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Region (2021-2032)
  3. 6.2.1 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Region: 2021-2026
  4. 6.2.2 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Continuous Glucose Monitor (CGM) Solution Sales Value (2021-2032)
  7. 6.3.2 North America Continuous Glucose Monitor (CGM) Solution Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Continuous Glucose Monitor (CGM) Solution Sales Value (2021-2032)
  10. 6.4.2 Europe Continuous Glucose Monitor (CGM) Solution Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Continuous Glucose Monitor (CGM) Solution Sales Value (2021-2032)
  16. 6.6.2 South America Continuous Glucose Monitor (CGM) Solution Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Continuous Glucose Monitor (CGM) Solution Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Continuous Glucose Monitor (CGM) Solution Sales Value Share by Country, 2025 VS 2032
7 Continuous Glucose Monitor (CGM) Solution Country-level Value Analysis
  1. 7.1 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Country (2021-2032)
  3. 7.2.1 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Country (2021-2026)
  4. 7.2.2 Global Continuous Glucose Monitor (CGM) Solution Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Continuous Glucose Monitor (CGM) Solution Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Continuous Glucose Monitor (CGM) Solution Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Continuous Glucose Monitor (CGM) Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Continuous Glucose Monitor (CGM) Solution Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Nutrisense
  8. 8.2.1 Nutrisense Company Information
  9. 8.2.2 Nutrisense Business Overview
  10. 8.2.3 Nutrisense Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nutrisense Continuous Glucose Monitor (CGM) Solution Product Portfolio
  12. 8.2.5 Nutrisense Recent Developments
  13. 8.3 Levels Health
  14. 8.3.1 Levels Health Company Information
  15. 8.3.2 Levels Health Business Overview
  16. 8.3.3 Levels Health Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Levels Health Continuous Glucose Monitor (CGM) Solution Product Portfolio
  18. 8.3.5 Levels Health Recent Developments
  19. 8.4 Eversense
  20. 8.4.1 Eversense Company Information
  21. 8.4.2 Eversense Business Overview
  22. 8.4.3 Eversense Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eversense Continuous Glucose Monitor (CGM) Solution Product Portfolio
  24. 8.4.5 Eversense Recent Developments
  25. 8.5 Abbott
  26. 8.5.1 Abbott Company Information
  27. 8.5.2 Abbott Business Overview
  28. 8.5.3 Abbott Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Abbott Continuous Glucose Monitor (CGM) Solution Product Portfolio
  30. 8.5.5 Abbott Recent Developments
  31. 8.6 Dexcom
  32. 8.6.1 Dexcom Company Information
  33. 8.6.2 Dexcom Business Overview
  34. 8.6.3 Dexcom Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Dexcom Continuous Glucose Monitor (CGM) Solution Product Portfolio
  36. 8.6.5 Dexcom Recent Developments
  37. 8.7 Medtronic
  38. 8.7.1 Medtronic Company Information
  39. 8.7.2 Medtronic Business Overview
  40. 8.7.3 Medtronic Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Medtronic Continuous Glucose Monitor (CGM) Solution Product Portfolio
  42. 8.7.5 Medtronic Recent Developments
  43. 8.8 Changsha Sinocare
  44. 8.8.1 Changsha Sinocare Company Information
  45. 8.8.2 Changsha Sinocare Business Overview
  46. 8.8.3 Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Product Portfolio
  48. 8.8.5 Changsha Sinocare Recent Developments
  49. 8.9 Beijing Yicheng Bioelectronics Technology
  50. 8.9.1 Beijing Yicheng Bioelectronics Technology Company Information
  51. 8.9.2 Beijing Yicheng Bioelectronics Technology Business Overview
  52. 8.9.3 Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Product Portfolio
  54. 8.9.5 Beijing Yicheng Bioelectronics Technology Recent Developments
  55. 8.10 Ottai Technology (Wuxi)
  56. 8.10.1 Ottai Technology (Wuxi) Company Information
  57. 8.10.2 Ottai Technology (Wuxi) Business Overview
  58. 8.10.3 Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Product Portfolio
  60. 8.10.5 Ottai Technology (Wuxi) Recent Developments
  61. 8.11 Hangzhou MicroTech Medical
  62. 8.11.1 Hangzhou MicroTech Medical Company Information
  63. 8.11.2 Hangzhou MicroTech Medical Business Overview
  64. 8.11.3 Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Product Portfolio
  66. 8.11.5 Hangzhou MicroTech Medical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst